FDA NDC
RETACRIT
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 59353-220
- Proprietary name
- RETACRIT
- Nonproprietary name
- epoetin alfa-epbx
- Labeler
- Vifor (International) Inc.
- Dosage form
- INJECTION, SOLUTION
- Strength
- 10000 [iU]/mL
Run it in Rivvi
Which 2027 plans near you dropped or restricted epoetin alfa-epbx?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.